FDA approves 1st COVID-19 drug: the antiviral remdesivir

The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health.

Associated Press

Oct 22, 2020, 10:20 PM

Updated 1,370 days ago

Share:

FDA approves 1st COVID-19 drug: the antiviral remdesivir
U.S. regulators on Thursday approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given to hospitalized patients through an IV.
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health.
It had been authorized for use on an emergency basis since spring, and now becomes the first drug to win full Food and Drug Administration approval for treating COVID-19. President Donald Trump received it when he was sickened earlier this month.
Veklury is approved for people at least 12 years old and weighing at least 88 pounds (40 kilograms) who are hospitalized for a coronavirus infection. For patients younger than 12, the FDA will still allow the drug’s use in certain cases under its previous emergency authorization.
The drug works by inhibiting a substance the virus uses to make copies of itself. Certain kidney and liver tests are required before starting patients on it to ensure it's safe for them and to monitor for any possible side effects. And the label warns against using it with the malaria drug hydroxychloroquine, because that can curb its effectiveness.
“We now have enough knowledge and a growing set of tools to help fight COVID-19,” Gilead's chief medical officer, Dr. Merdad Parsey, said in a statement.
The drug is either approved or has temporary authorization in about 50 countries, he noted.
Its price has been controversial, given that no studies have found it improves survival. Last week, a large study led by the World Health Organization found the drug did not help hospitalized COVID-19 patients, but that study did not include a placebo group and was less rigorous than previous ones that found a benefit. The FDA's approval statement noted that, besides the NIH-led one, two other studies found the drug beneficial.
Gilead charges $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries, and $3,120 for patients with private insurance. The amount that patients pay out of pocket depends on insurance, income and other factors.
So far, only steroids such as dexamethasone have been shown to cut the risk of dying of COVID-19. The FDA also has given emergency authorization to using the blood of survivors, and two companies are currently seeking similar authorization for experimental antibody drugs.


More from News 12
1:38
Police: Man arrested for slashing woman during domestic dispute in Yonkers

Police: Man arrested for slashing woman during domestic dispute in Yonkers

2:18
Warm and humid with possible showers today, nicer weather coming in 48 hours!

Warm and humid with possible showers today, nicer weather coming in 48 hours!

1:47
'I don't know what the answer is.' Newburgh residents may have to live with dangerous intersection indefinitely

'I don't know what the answer is.' Newburgh residents may have to live with dangerous intersection indefinitely

1:22
How are young Hudson Valley voters feeling about the possibility of Kamala Harris as the Democratic nominee for president?

How are young Hudson Valley voters feeling about the possibility of Kamala Harris as the Democratic nominee for president?

2:24
Tackling flooding in the Town of Mamaroneck, engineering consultant looks into options

Tackling flooding in the Town of Mamaroneck, engineering consultant looks into options

1:29
Oklahoma woman sentenced to 4-12 years for fatal drunk-driving crash in Newburgh

Oklahoma woman sentenced to 4-12 years for fatal drunk-driving crash in Newburgh

1:48
A look back at President Biden, VP Harris' visits to the Hudson Valley

A look back at President Biden, VP Harris' visits to the Hudson Valley

0:48
Made in the Hudson Valley: 'Mister Croissant' bakery brings world-class pastries to Middletown

Made in the Hudson Valley: 'Mister Croissant' bakery brings world-class pastries to Middletown

0:43
Secret Service director steps down after assassination attempt against ex-President Trump at rally

Secret Service director steps down after assassination attempt against ex-President Trump at rally

0:28
Orange County man fatally struck in hit-and-run crash in the Bronx; man charged

Orange County man fatally struck in hit-and-run crash in the Bronx; man charged

0:21
$17 million awarded to repair Callicoon Bridge in Sullivan County

$17 million awarded to repair Callicoon Bridge in Sullivan County

0:27
New York, New Jersey & Delaware sued for failing to protect endangered Atlantic sturgeon

New York, New Jersey & Delaware sued for failing to protect endangered Atlantic sturgeon

1:02
Headlines: New Rochelle stabbing, home burglary, New Rochelle man pleads guilty in Bronx shooting

Headlines: New Rochelle stabbing, home burglary, New Rochelle man pleads guilty in Bronx shooting

Special election in Yorktown will fill vacant Town Council seat

Special election in Yorktown will fill vacant Town Council seat

0:54
Jayne Street Bridge in Orange County gets $1.35M boost for restoration

Jayne Street Bridge in Orange County gets $1.35M boost for restoration

2:27
Made in the Hudson Valley: Hudson Beach Glass gives visitors the chance to become glassblowers themselves

Made in the Hudson Valley: Hudson Beach Glass gives visitors the chance to become glassblowers themselves

0:21
Eastchester police mourn loss of former officer Alex Bonci

Eastchester police mourn loss of former officer Alex Bonci

2:09
Hudson Valley congressman backs Vice President Kamala Harris for new presidential nominee

Hudson Valley congressman backs Vice President Kamala Harris for new presidential nominee

1:19
Bullet pierces through home in Middletown, police search for shooter

Bullet pierces through home in Middletown, police search for shooter

AP survey: Harris has enough delegate support to become the Democratic Party nominee

AP survey: Harris has enough delegate support to become the Democratic Party nominee